Vitamin D Deficiency (Adults) - Osteomalacia
Overview
Plain-Language Overview
Vitamin D Deficiency (Adults) - Osteomalacia is a condition where the bones become soft and weak due to a lack of vitamin D, which is essential for healthy bone formation. This condition affects the skeletal system and can cause symptoms like bone pain, muscle weakness, and increased risk of fractures. Vitamin D helps the body absorb calcium and phosphorus, minerals critical for strong bones. Without enough vitamin D, bones lose their strength and flexibility, leading to discomfort and difficulty with movement. It often develops slowly and may be linked to poor diet, limited sun exposure, or problems with vitamin D metabolism.
Clinical Definition
Vitamin D Deficiency (Adults) - Osteomalacia is characterized by defective bone mineralization due to inadequate levels of 25-hydroxyvitamin D, leading to accumulation of unmineralized osteoid. The core pathology involves impaired intestinal absorption of calcium and phosphorus, resulting in hypocalcemia and secondary hyperparathyroidism. This causes increased bone resorption and defective bone remodeling. The usual causes include insufficient dietary intake, inadequate sunlight exposure, malabsorption syndromes, or chronic kidney disease affecting vitamin D metabolism. Clinically, it presents with diffuse bone pain, proximal muscle weakness, and increased susceptibility to fractures. Laboratory findings typically show low serum 25(OH)D, low or normal calcium, low phosphorus, elevated alkaline phosphatase, and secondary hyperparathyroidism. Radiographs may reveal pseudofractures or Looser zones, which are pathognomonic.
Inciting Event
Prolonged vitamin D deficiency from inadequate dietary intake or sunlight exposure.
Malabsorption of vitamin D due to gastrointestinal diseases or surgeries.
Chronic renal insufficiency impairing 1-alpha hydroxylase activity.
Medications inducing vitamin D metabolism such as anticonvulsants or glucocorticoids.
Latency Period
Months to years of sustained vitamin D deficiency are typically required before clinical osteomalacia develops.
Gradual onset of symptoms occurs as bone demineralization progresses.
Symptom onset may be delayed in patients with partial vitamin D deficiency or intermittent exposure.
Diagnostic Delay
Nonspecific symptoms such as diffuse bone pain and muscle weakness often mimic other musculoskeletal disorders.
Normal or mildly decreased serum calcium can mislead clinicians away from vitamin D deficiency.
Lack of routine vitamin D level testing in patients with bone pain delays diagnosis.
Radiographic changes may be subtle or absent early in disease, leading to missed diagnosis.
Clinical Presentation
Signs & Symptoms
Diffuse bone pain and tenderness, often worse at night
Muscle weakness, especially proximal muscles
Difficulty walking and frequent falls
Fractures with minimal trauma
Fatigue and generalized malaise
History of Present Illness
Progressive diffuse bone pain, especially in the lower back, hips, and legs.
Proximal muscle weakness causing difficulty climbing stairs or rising from a chair.
Fatigue and generalized weakness develop insidiously over months.
History of fractures or skeletal deformities may be present in advanced cases.
Past Medical History
History of malabsorptive disorders such as celiac disease or bariatric surgery.
Chronic kidney or liver disease impairing vitamin D metabolism.
Use of medications like anticonvulsants or glucocorticoids that affect vitamin D levels.
Previous fractures or bone pain suggestive of underlying metabolic bone disease.
Family History
Usually negative for inherited bone disorders as osteomalacia is primarily acquired.
Rare familial forms of vitamin D–dependent rickets may be considered if early onset occurs.
No consistent familial pattern in typical adult osteomalacia cases.
Physical Exam Findings
Bone tenderness on palpation, especially over the ribs, pelvis, and long bones
Proximal muscle weakness with difficulty rising from a chair or climbing stairs
Waddling gait due to hip girdle muscle weakness
Skeletal deformities such as bowing of the legs or pelvic deformities in severe cases
Fractures with minimal trauma, often involving ribs, femur, or vertebrae
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by demonstrating low serum 25-hydroxyvitamin D levels combined with clinical features of bone pain and muscle weakness. Laboratory tests show low or normal serum calcium, low phosphorus, elevated alkaline phosphatase, and elevated parathyroid hormone due to secondary hyperparathyroidism. Radiographic evidence of Looser zones (pseudofractures) supports the diagnosis. Bone biopsy with tetracycline labeling can confirm defective mineralization if diagnosis is uncertain.
Pathophysiology
Key Mechanisms
Decreased intestinal absorption of calcium due to low serum 1,25-dihydroxyvitamin D levels impairs bone mineralization.
Secondary hyperparathyroidism develops as a compensatory response to hypocalcemia, increasing bone resorption.
Defective mineralization of osteoid matrix leads to accumulation of unmineralized bone, causing osteomalacia.
Hypophosphatemia results from increased renal phosphate wasting driven by elevated parathyroid hormone.
| Involvement | Details |
|---|---|
| Organs | Kidneys convert 25-hydroxyvitamin D to active 1,25-dihydroxyvitamin D, a critical step impaired in some causes of osteomalacia. |
Parathyroid glands secrete PTH in response to hypocalcemia caused by vitamin D deficiency, exacerbating bone resorption. | |
Skin synthesizes vitamin D3 upon ultraviolet B radiation exposure, initiating vitamin D metabolism. | |
| Tissues | Bone tissue exhibits defective mineralization in osteomalacia, leading to softening and increased fracture risk. |
Intestinal mucosa is the site of vitamin D–mediated calcium absorption, which is impaired in deficiency states. | |
| Cells | Osteoblasts are responsible for bone formation and are stimulated by active vitamin D to mineralize osteoid. |
Osteoclasts resorb bone and are indirectly regulated by vitamin D through calcium and phosphate homeostasis. | |
| Chemical Mediators | 1,25-dihydroxyvitamin D (Calcitriol) is the active form of vitamin D that increases intestinal calcium absorption and bone mineralization. |
Parathyroid hormone (PTH) is elevated in vitamin D deficiency, promoting bone resorption to maintain serum calcium. | |
Alkaline phosphatase is elevated in osteomalacia due to increased osteoblastic activity during defective bone mineralization. |
Treatments
Pharmacological Treatments
Vitamin D3 (Cholecalciferol) or Vitamin D2 (Ergocalciferol)
- Mechanism:
Restores serum 25-hydroxyvitamin D levels to enhance intestinal calcium absorption and bone mineralization.
- Side effects:
Hypercalcemia
Hypercalciuria
Nephrolithiasis
- Clinical role:
First-line
Calcium supplementation
- Mechanism:
Provides essential calcium to support bone mineralization alongside vitamin D therapy.
- Side effects:
Constipation
Hypercalcemia
Kidney stones
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Increase safe sunlight exposure to promote endogenous vitamin D synthesis in the skin.
Implement dietary modifications to include calcium-rich foods such as dairy products and leafy greens.
Encourage weight-bearing exercise to improve bone strength and reduce fracture risk.
Prevention
Pharmacological Prevention
Vitamin D3 (cholecalciferol) supplementation to maintain adequate serum levels
Calcium supplementation to support bone mineralization
Active vitamin D analogs (calcitriol) in cases of renal impairment
Monitoring and adjusting doses in patients on anticonvulsants
Regular serum 25-hydroxyvitamin D level checks to guide therapy
Non-pharmacological Prevention
Adequate sunlight exposure to promote endogenous vitamin D synthesis
Diet rich in vitamin D and calcium including fortified foods and fatty fish
Screening high-risk populations such as elderly and malabsorptive disorders
Weight-bearing exercises to strengthen bones and muscles
Avoidance of factors impairing vitamin D metabolism such as excessive alcohol
Outcome & Complications
Complications
Pathologic fractures leading to disability
Severe muscle weakness causing falls and injury
Skeletal deformities impairing mobility
Secondary hyperparathyroidism causing bone resorption
Chronic pain syndrome with reduced quality of life
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Vitamin D Deficiency (Adults) - Osteomalacia versus Primary Hyperparathyroidism
Vitamin D Deficiency (Adults) - Osteomalacia | Primary Hyperparathyroidism |
|---|---|
Low or normal serum calcium with elevated PTH due to secondary hyperparathyroidism | Elevated serum calcium with elevated or inappropriately normal parathyroid hormone (PTH) |
Bone softening due to defective mineralization without hypercalcemia | Chronic hypercalcemia leading to bone resorption and kidney stones |
Looser zones (pseudofractures) and generalized osteopenia on X-ray | Osteitis fibrosa cystica with subperiosteal bone resorption on X-ray |
Vitamin D Deficiency (Adults) - Osteomalacia versus Hypophosphatasia
Vitamin D Deficiency (Adults) - Osteomalacia | Hypophosphatasia |
|---|---|
Elevated serum alkaline phosphatase due to increased osteoblastic activity | Low serum alkaline phosphatase (ALP) activity |
Low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels | Genetic testing showing mutations in ALPL gene |
Acquired deficiency due to nutritional or malabsorptive causes | Inherited disorder with variable onset from infancy to adulthood |
Vitamin D Deficiency (Adults) - Osteomalacia versus Renal Osteodystrophy
Vitamin D Deficiency (Adults) - Osteomalacia | Renal Osteodystrophy |
|---|---|
No history of renal impairment | History of chronic kidney disease or dialysis |
Low serum phosphate with elevated PTH secondary to vitamin D deficiency | Elevated serum phosphate and PTH with low or normal calcium |
Predominant osteomalacia with defective mineralization on biopsy | Mixed osteitis fibrosa and osteomalacia features on bone biopsy |
Vitamin D Deficiency (Adults) - Osteomalacia versus Osteoporosis
Vitamin D Deficiency (Adults) - Osteomalacia | Osteoporosis |
|---|---|
Low serum 25-hydroxyvitamin D and elevated alkaline phosphatase | Normal serum calcium, phosphate, and alkaline phosphatase |
Defective bone mineralization causing bone softening | Progressive loss of bone mass without defective mineralization |
Presence of Looser zones (pseudofractures) on X-ray | Reduced bone density without Looser zones or pseudofractures |
Vitamin D Deficiency (Adults) - Osteomalacia versus Paget Disease of Bone
Vitamin D Deficiency (Adults) - Osteomalacia | Paget Disease of Bone |
|---|---|
Elevated alkaline phosphatase with low calcium and phosphate | Markedly elevated alkaline phosphatase with normal calcium and phosphate |
Looser zones and generalized osteopenia without bone expansion | Thickened, disorganized bone with cortical thickening and bone expansion |
Diffuse bone softening due to defective mineralization | Focal bone disease with increased bone turnover |